Free shipping on all orders over $ 500

TM6008

Cat. No. M8979

All AbMole products are for research use only, cannot be used for human consumption.

TM6008 Structure
Size Price Availability
5mg USD 550 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TM6008 is a prolyl hydroxylase (PHD) inhibitor that protects against cell death after hypoxia. TM6008 suppresses the activity of PHDs, inducing continuous HIF-1α activation. Immunoblotting revealed that TM6008 increased the expression of HIF-1α, HIF-2α and vascular endothelial growth factor in myocarditis.

In vivo, TM6008 improved left ventricular ejection fraction significantly on the 21st day of EAM. Though TM6008 did not affect the severity of myocardial cell infiltration, it tended to reduce cardiac fibrosis. Immunohistochemistry showed that CD31-positive blood vessels were preserved in the TM6008 group compared to the control group. Immunoblotting revealed that TM6008 increased the expression of HIF-1α, HIF-2α and vascular endothelial growth factor in myocarditis. Oral administration of TM6008 protected neurons in a model of cerebrovascular disease.

Chemical Information
Molecular Weight 387.39
Formula C21H17N5O3
CAS Number 945008-17-3
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Tada Y, et al. Expert Opin Investig Drugs. Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis.

[2] Kontani S, et al. Neurochem Res. A novel prolyl hydroxylase inhibitor protects against cell death after hypoxia.

[3] Takizawa S, et al. Rinsho Shinkeigaku. [Novel neuroprotective agents: a HIF activator and an Akt activator].

[4] Takeda K, et al. Arterioscler Thromb Vasc Biol. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.

[5] Nangaku M, et al. Arterioscler Thromb Vasc Biol. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.

Related HIF Products
FG-4592 (Roxadustat)

FG-4592 (Roxadustat; ASP1517) is a novel Hypoxia Inducible Factor Prolyl Hydroxylase inhibitor.

2-Methoxyestradiol

2-methoxyestradiol (2-ME2), an endogenous metabolite of 17β -estradiol (E2) with oral activity, is an apoptosis inducer and angiogenesis inhibitor with effective antitumor activity. Methoxyestradiol can also destabilize microtubules. Methoxyestradiol is a potent inhibitor of superoxide dismutase (SOD) and reactive oxygen species (ROS) that can induce autophagy in transformed cell line HEK293, cancer cell line U87 and HeLa.

DMOG

DMOG (Dimethyloxaloyl glycine) is an antagonist of α-ketoglutarate cofactor and a cell permeable and competitive inhibitor of HIF-PH, which results in HIF-1α stabilisation and accmulation in vitro and in vivo. DMOG acts as a pro-angiogenic agent and plays a protective role in experimental model of colitis and diarrhoea via HIF-1 related signal. DMOG induces cell autophagy.

IOX2

IOX2 is a potent inhibitor of HIF-1α prolyl hydroxylase-2 (PHD2) with IC50 of 21 nM, >100-fold selectivity over JMJD2A, JMJD2C, JMJD2E, JMJD3, or the 2OG oxygenase FIH.

Hydralazine hydrochloride

Hydralazine hydrochloride is a hydrochloride salt of hydralazine (Apresoline) that is a direct-acting smooth muscle relaxant with an IC50 of 1.9 mM.

  Catalog
Abmole Inhibitor Catalog




Keywords: TM6008 supplier, HIF, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.